Navigation Links
Influenza drug delayed

The maker of the only medication approved to treat both major strains of influenza in young children said the drug was not available for the start of this flu season because production problems delayed its distribution. The medication, Tamiflu Oral Suspension product, was supposed to be launched this season. Hoffmann-La Roche informed the FDA of its production problems, but FDA spokeswoman Sharon Jayne said the company was not required to do so. //

Tamiflu is one of two FDA approved drugs in a new class of medications, which attack the virus that causes the flu and stops it from spreading. The other medication, Relenza, is equally effective but can cause more side effects and is more difficult to use since it is inhaled twice a day. Both medications must be used within two days of developing symptoms to be effective.

Tamiflu pills for adults and older children were approved by the U.S. Food and Drug Administration in October 1999 and are available. The liquid formula for children 1 or older was approved in December 2000, but was not available until January 2001. Flu season usually occurs between December and April.

Tamiflu can shorten the duration of the flu by one to two days and reduce major complications such as ear infections and bronchitis. Ear infections, the most common complication in children, can be reduced by 44 percent. Tamiflu can reduce the spread of flu in families. When the first person in a household who developed the flu took the drug as well as all other family members, 63 percent of the households were protected against the flu. The results with this drug are marvelous. Two other flu medications, amantadine and rimantadine, are available but only treat Influenza A.
'"/>




Page: 1

Related medicine news :

1. Chances are high for Avian Influenza virus altering its form
2. Influenza Avian Flu strain has become more contagious and dangerous.
3. A Vaccine for the impending pandemic Avian Influenza
4. Influenza Vaccination for children with neurological or neuromuscular disease
5. Avian Influenza: Government to set up expert committee
6. Resistant Influenza strains creates panic in US
7. Influenza Vaccination For The Elderly
8. Fao Declares Humans Spread Avian Influenza Virus
9. Statins Could Play Important Role In Influenza Pandemic
10. Zoo Animal Succumbs to Avian Influenza in Germany
11. India Says It Is ‘‘Avian Influenza Free Country
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: